End-of-day quote
Other stock markets
|
||
- | - |
Chart calendar Inotek Pharmaceuticals Corp
Upcoming events on Inotek Pharmaceuticals Corp
Past events on Inotek Pharmaceuticals Corp
09/04/2024 | Needham Healthcare Conference |
12/03/2024 05:30 pm | Leerink Partners Global Biopharma Conference |
07/03/2024 | Q4 2023 Earnings Release (Projected) |
06/03/2024 12:40 am | TD Cowen Health Care Conference |
09/01/2024 05:15 am | JPMorgan Healthcare Conference |
30/11/2023 11:50 pm | Evercore ISI HealthCONx Conference |
15/11/2023 09:25 pm | Stifel Healthcare Conference |
07/11/2023 02:34 am | Q3 2023 Earnings Release |
27/10/2023 02:30 pm | European Society of Gene and Cell Therapy Conference - Jonathan Schwartz |
27/10/2023 12:00 am | European Society of Gene and Cell Therapy Conference - Poster Number: P067 |
26/10/2023 12:30 pm | European Society of Gene and Cell Therapy Conference - Paula Río |
25/10/2023 08:30 pm | European Society of Gene and Cell Therapy Conference - Poster Number: P067 |
25/10/2023 06:00 pm | European Society of Gene and Cell Therapy Conference - Kinnari Patel |
24/10/2023 08:30 pm | European Society of Gene and Cell Therapy Conference - Julián Sevilla |
11/10/2023 | Cell & Gene Meeting on the Mesa Conference |
03/10/2023 10:30 pm | Chardan Genetic Medicines Conference |
28/09/2023 08:25 pm | Cantor Global Healthcare Conference |
12/09/2023 07:40 pm | Morgan Stanley Global Healthcare Conference |
10/08/2023 04:30 pm | Q2 2023 Earnings Release |
22/06/2023 06:30 pm | Annual General Meeting |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,10 - | 0,00 0,00 - | 29,5 |
EBITDA Million USD | Released Forecast Spread | -76,1 -91,0 16.43% | -133 -102 -30.77% | -164 -153 -7.29% | -189 -193 2% | -255 -266 4.08% | -233 |
EBIT Million USD | Released Forecast Spread | -76,2 -82,7 7.93% | -134 -104 -28.96% | -167 -170 1.59% | -224 -214 -4.71% | -260 -265 2.14% | -265 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -77,3 -84,7 8.82% | -140 -110 -27.56% | -169 -172 1.52% | -222 -216 -2.78% | -246 -252 2.72% | -271 |
Net income Million USD | Released Forecast Spread | -77,3 -84,1 8.08% | -140 -109 -27.86% | -169 -172 1.46% | -222 -215 -3.01% | -246 -253 2.94% | -262 |
EPS USD | Released Forecast Spread | -1,58 -1,68 5.7% | -2,52 -1,93 -30.29% | -2,67 -2,64 -1.21% | -3,26 -3,14 -3.8% | -2,92 -3,00 2.81% | -2,66 |
Announcement Date | 05/03/20 | 25/02/21 | 24/02/22 | 27/02/23 | 26/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,11 | 4,39 | 29,0 | 33,2 |
EBITDA Million USD | Released Forecast Spread | -43,3 -44,5 2.64% | -53,2 -43,6 -22.08% | -49,7 -47,5 -4.77% | -58,3 -45,3 -28.67% | -52,1 -55,4 5.92% | -57,3 -65,6 12.57% | -53,9 -70,5 23.53% | -61,9 -73,6 15.95% | -63,7 | -70,0 | -61,1 | -20,2 | ||
EBIT Million USD | Released Forecast Spread | -44,3 -46,2 4.03% | -42,6 -48,0 11.39% | -54,2 -44,4 -21.97% | -58,5 -53,5 -9.25% | -69,1 -59,3 -16.41% | -62,2 -65,4 4.95% | -68,8 -63,2 -8.83% | -65,4 -72,5 9.72% | -63,3 -69,0 8.3% | -63,9 | -67,1 | -68,1 | -50,3 | -40,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -44,2 -45,3 2.22% | -43,0 -47,0 8.45% | -54,4 -44,6 -21.91% | -57,8 -54,6 -5.73% | -66,7 -60,6 -10.07% | -58,3 -64,0 8.87% | -65,7 -61,8 -6.31% | -61,9 -69,3 10.62% | -59,7 -66,7 10.57% | -64,3 | -66,3 | -67,5 | -65,2 | -39,9 |
Net income Million USD | Released Forecast Spread | -44,2 -46,0 3.82% | -43,0 -46,7 8.01% | -54,4 -44,5 -22.37% | -57,8 -52,4 -10.19% | -66,7 -60,1 -11.11% | -58,3 -64,6 9.72% | -65,7 -62,9 -4.48% | -61,9 -68,8 10.03% | -59,7 -66,9 10.83% | -61,1 | -63,8 | -64,6 | -63,5 | -39,9 |
EPS USD | Released Forecast Spread | -0,69 -0,73 5.43% | -0,67 -0,70 4.72% | -0,83 -0,68 -21.55% | -0,87 -0,79 -9.48% | -0,89 -0,82 -8.33% | -0,73 -0,82 11.41% | -0,82 -0,79 -3.78% | -0,75 -0,80 6.64% | -0,64 -0,78 17.72% | -0,67 | -0,70 | -0,71 | -0,66 | -0,45 |
Announcement Date | 24/02/22 | 05/05/22 | 08/08/22 | 03/11/22 | 27/02/23 | 04/05/23 | 09/08/23 | 07/11/23 | 26/02/24 | - | - | - | - | - |
Past sector events for Inotek Pharmaceuticals Corp
03/05/2024 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
02/05/2024 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
02/05/2024 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
02/05/2024 04:00 pm | SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
02/05/2024 04:00 pm | REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
02/05/2024 03:30 pm | AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release |
02/05/2024 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
02/05/2024 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
02/05/2024 | GERON CORPORATION: Q1 2024 Earnings Release |
02/05/2024 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- RCKT Stock
- Stock
- Calendar Inotek Pharmaceuticals Corp